Cargando…

CITCO as an Adjuvant Facilitates CHOP-Based Lymphoma Treatment in hCAR-Transgenic Mice

Non-Hodgkin’s lymphoma (NHL) is a malignant cancer originating in the lymphatic system with a 25–30% mortality rate. CHOP, consisting of cyclophosphamide (CPA), doxorubicin, vincristine, and prednisone, is a first-generation chemotherapy extensively used to treat NHL. However, poor survival rates am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurian, Ritika, Hedrich, William, Mackowiak, Bryan, Li, Linhao, Wang, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700167/ https://www.ncbi.nlm.nih.gov/pubmed/33233444 http://dx.doi.org/10.3390/cells9112520

Ejemplares similares

Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells
por: Chakraborty, S, et al.
Publicado: (2011)

55484 Dual activation of CAR and Nrf2 improves the efficacy: toxicity ratio of cyclophosphamide and doxorubicin-based treatment of TNBC
por: Stern, Sydney, et al.
Publicado: (2021)

Orthosteric and allosteric modulation of human HCAR2 signaling complex
por: Mao, Chunyou, et al.
Publicado: (2023)

Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1
por: Morland, Cecilie, et al.
Publicado: (2017)

Lack of HCAR1, the lactate GPCR, signaling promotes autistic-like behavior
por: Mohammad Nezhady, Mohammad Ali, et al.
Publicado: (2023)

Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

Participation of L-Lactate and Its Receptor HCAR1/GPR81 in Neurovisual Development
por: Laroche, Samuel, et al.
Publicado: (2021)

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2
por: Cheng, Lin, et al.
Publicado: (2023)

Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2
por: Pan, Xin, et al.
Publicado: (2023)

R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies
por: Echenique, Ignacio, et al.
Publicado: (2012)

Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma
por: Harun-Or-Rashid, Mohammad, et al.
Publicado: (2018)

Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer
por: Yang, Xuan, et al.
Publicado: (2021)

Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma
por: Longhitano, Lucia, et al.
Publicado: (2022)

Lactate receptor HCAR1 regulates neurogenesis and microglia activation after neonatal hypoxia-ischemia
por: Kennedy, Lauritz, et al.
Publicado: (2022)

Clinical Response to CHOP vs. R-CHOP in Adult Patients with Diffuse Large B-Cell Lymphomas
por: Tariq, Ayesha, et al.
Publicado: (2018)

Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy
por: Guo, Wei, et al.
Publicado: (2015)

The lymphoma microenvironment comes of age in the R-CHOP era?
por: Cooper, Alan, et al.
Publicado: (2023)

Analysis of genetic heterogeneity in the HCAR adenovirus-binding Ig1 domain in a Caucasian Flemish population
por: Thoelen, Inge, et al.
Publicado: (2002)

HCAR Is a Limitation Factor for Chlorophyll Cycle and Chlorophyll b Degradation in Chlorophyll-b-Overproducing Plants
por: Zhao, Xuan, et al.
Publicado: (2020)

Lactate Neuroprotection against Transient Ischemic Brain Injury in Mice Appears Independent of HCAR1 Activation
por: Buscemi, Lara, et al.
Publicado: (2022)

Adipose-derived mesenchymal stem cell-derived HCAR1 regulates immune response in the attenuation of sepsis
por: Wang, Hongyan, et al.
Publicado: (2022)

Activation of lactate receptor HCAR1 down-modulates neuronal activity in rodent and human brain tissue
por: Briquet, Marc, et al.
Publicado: (2022)

Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes
por: Li, Zhihui, et al.
Publicado: (2021)

Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen
por: Chen, Xing-Gui, et al.
Publicado: (2011)

An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
por: Lu, Yaxiao, et al.
Publicado: (2021)

RNA disruption indicates CHOP therapy efficacy in canine lymphoma
por: Parissenti, Amadeo M., et al.
Publicado: (2019)

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
por: Terada, Yoshiki, et al.
Publicado: (2009)

Evaluation of Hydroxycarboxylic Acid Receptor 1 (HCAR1) as a Building Block for Genetically Encoded Extracellular Lactate Biosensors
por: Wellbourne-Wood, Joel, et al.
Publicado: (2022)

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
por: Zhang, Qunling, et al.
Publicado: (2016)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
por: Grigg, Andrew, et al.
Publicado: (2017)

Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients
por: Huang, Ying, et al.
Publicado: (2012)

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma
por: Nowakowski, Grzegorz S, et al.
Publicado: (2016)

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14
por: Gutiérrez, Antonio, et al.
Publicado: (2015)

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study
por: Wakasugi, Yoshinori, et al.
Publicado: (2019)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
por: Zhang, Yu, et al.
Publicado: (2021)

Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis
por: Painschab, Matthew S, et al.
Publicado: (2021)

Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
por: Parodi, Benedetta, et al.
Publicado: (2015)

Lactate receptor HCAR1 regulates cell growth, metastasis and maintenance of cancer-specific energy metabolism in breast cancer cells
por: Jin, Lili, et al.
Publicado: (2022)

A GPCR screening in human keratinocytes identifies that the metabolite receptor HCAR3 controls epithelial proliferation, migration, and cellular respiration
por: Pedro, M. Pilar, et al.
Publicado: (2023)

Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
por: Hong, Junshik, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9lijtgd3tc7sfr0av8skhc7p3s